Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4291 AL 4305

Plant-derived exosome-like nanovesicles: mechanisms and molecular understanding in neurological disorders with potential therapeutic applications

Isik S, Alhelwani S, Sahsahi A, Balcilar H, Yeman-Kiyak B.

Drug Deliv Transl Res. 2025 Dec;15(12):4452-4478. doi: 10.1007/s13346-025-01955-0. Epub 2025 Aug 20.

Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's disease

Morizane A, Yamasaki E, Shindo T, Anazawa T, Sawamoto N, Shima A, Yamakado H, Nakanishi E, Sawamura M, Taruno Y, Doi D, Kikuchi T, Kawasaki Y, Saito MK, Kikuchi T, Arakawa Y, Miyamoto S, Nakamoto Y, Takahashi R, Takahashi J.

Cell Stem Cell. 2025 Sep 4;32(9):1346-1355.e3. doi: 10.1016/j.stem.2025.07.012. Epub 2025 Aug 19.

Tackling a disease on a global scale, the Global Parkinson's Genetics Program, GP2: A new generation of opportunities

Blauwendraat C, Noyce AJ, Mata IF, Screven LA, Solle J, Dumanis SB, Riley EA, Periñan MT, Okubadejo N, Klein C, Morris HR, Singleton AB; Global Parkinson’s Genetics Program (GP2).

Am J Hum Genet. 2025 Sep 4;112(9):1988-2000. doi: 10.1016/j.ajhg.2025.07.014. Epub 2025 Aug 19.

The role of mitophagy in perioperative neurocognitive disorder: from mechanisms to implications

Gao S, Wang J, Chen J.

Neuroscience. 2025 Oct 1;584:160-165. doi: 10.1016/j.neuroscience.2025.08.028. Epub 2025 Aug 18.

The evolution of axial postural abnormality in Parkinson's disease: a 3-year longitudinal observational study

Wu Z, Hong R, Zhang Z, Zhu S, Peng Y, Zhang J, Guan Q, Pan L, Chen Y, Jin L.

Neurol Sci. 2025 Oct;46(10):5035-5047. doi: 10.1007/s10072-025-08375-5. Epub 2025 Aug 21.

Revamping Parkinson's disease therapy using PLGA-based drug delivery systems

Lababidi JM, Azzazy HME.

NPJ Parkinsons Dis. 2025 Aug 20;11(1):248. doi: 10.1038/s41531-025-01081-1.

Pharmacotherapeutic potential of daidzein: insights into mechanisms and clinical relevance

Praisthy Lj C, Kushwah R, Dubey S, Kumar V, Jain S.

Inflammopharmacology. 2025 Sep;33(9):5145-5171. doi: 10.1007/s10787-025-01891-y. Epub 2025 Aug 20.

Do we need drugs for psychiatric symptoms specifically for Parkinson's disease?

Mills KA, Pontone GM.

J Parkinsons Dis. 2025 Aug 21:1877718X251370970. doi: 10.1177/1877718X251370970. Online ahead of print.

Spontaneous swallowing frequency in the evaluation of swallowing function

Guidotti L, Españo D, Tomsen N, Clavé P, Ortega O.

Expert Rev Gastroenterol Hepatol. 2025 Sep;19(9):985-1005. doi: 10.1080/17474124.2025.2550525. Epub 2025 Sep 1.

Successful splenic arteriovenous shunt embolization for hepatic encephalopathy associated with splenic arteriovenous shunt and intrahepatic portosystemic venous shunt

Ishikawa K, Kawakura K, Inoue T, Miyagawa K, Imai S.

Radiol Case Rep. 2025 Aug 13;20(11):5523-5526. doi: 10.1016/j.radcr.2025.07.036. eCollection 2025 Nov.

An Interdisciplinary Approach to Assistive Technology for Parkinson's Disease Dementia

Munzesheimer S, Siu TWT, Yacinthe D, Garcia-Casals M, Haq IU, Shpiner DS.

Clin Interv Aging. 2025 Aug 15;20:1253-1265. doi: 10.2147/CIA.S516786. eCollection 2025.

Correction: Online training program maintains motor functions and quality of life in patients with Parkinson's disease

Nakanishi H, Morigaki R, Fujikawa J, Ohmae H, Shinohara K, Yamamoto N, Izumi Y, Takagi Y.

Front Digit Health. 2025 Aug 5;7:1672261. doi: 10.3389/fdgth.2025.1672261. eCollection 2025.

Effects of transcranial direct current stimulation using a commercially available device on gait in Parkinson's disease with freezing of gait

Umemura A, Sato K, Iwamuro H, Uchiyama S, Yanagisawa N, Kondo A, Hattori N.

PLoS One. 2025 Aug 21;20(8):e0330286. doi: 10.1371/journal.pone.0330286. eCollection 2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias